Pupulin SA et al., 2016: Conference abstract of a study combining a water-soluble coenzyme Q10 formulation (Ubisol-Q10) with methylene blue in transgenic mice expressing human amyloid precursor protein, with behavioural, ELISA and immunohistochemistry endpoints. The abstract states objectives only; no doses or results are given.
Our objective is to use a combination of both Ubisol-Q10 and methylene blue to study how efficient this coalition of treatments is in postponing premature senescence in the same transgenic mice.
Pupulin SA et al., 2016: Conference abstract of a study combining a water-soluble coenzyme Q10 formulation (Ubisol-Q10) with methylene blue in transgenic mice expressing human amyloid precursor protein, with behavioural, ELISA and immunohistochemistry endpoints. The abstract states objectives only; no doses or results are given. Study type: animal (transgenic mouse) conference abstract; N not stated; Canada. Doses/routes not reported in the abstract (full PDF not retrieved – 7.35 MB file listed but not downloaded). Authors affiliated with Pandey lab (Ubisol-Q10 developer). No results in abstract; treat as planned/ongoing work, not efficacy evidence.
